MT Newswires
Ideaya Biosciences Says 1st Patient Enrolled in Phase 1 Clinical Trial of Solid Tumors; Shares Up Pre-Bell
📊
AI Sentiment
Positive
7/10
Gilead Sciences Inc. News
Latest updates and market news for GILD
10 news
Mar 3 - Mar 9, 2026
Page 1
Simply Wall St.
Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Share Price Run
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Gilead’s BIC LEN HIV Results Highlight Valuation Gap And Future Potential
📈
AI Sentiment
Highly Positive
8/10
MarketBeat
These 3 Cash Flow Machines Provide Stability in Uncertain Markets
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
Gilead Sciences' HIV Drug Eyed for Local Production by South Africa
➖
AI Sentiment
Neutral
5/10
PR Newswire
Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies Accelerate Adoption | DelveInsight
📈
AI Sentiment
Highly Positive
9/10
Zacks
Gilead Sciences (GILD) Registers a Bigger Fall Than the Market: Important Facts to Note
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Gilead Sciences Arcellx Deal Deepens Oncology Bet And Tests HIV Reliance
📈
AI Sentiment
Highly Positive
8/10
Share this news page